LOS ANGELES, May 29, 2024 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results